Malaysia Hereditary Cancer Testing Market to 2032
Overview
The Malaysia Hereditary Cancer Testing Market is expected to reach a 62.54 USD Million by 2032 and is projected to grow at a CAGR of 19.71% from 2025 to 2032.
Revenue, 2024 (USD Million)
24.54
Forecast, 2032 (USD Million)
62.54
CAGR, 2024 - 2032
19.71%
Report Coverage
Malaysia
Malaysia Hereditary Cancer Testing Market 2018-2032 USD Million
Malaysia Hereditary Cancer Testing Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 24.54 USD Million
- Projected Market Size (2032): 62.54 USD Million
- CAGR (2025-2032): 19.71%
Key Findings of Malaysia Hereditary Cancer Testing Market
- The Malaysia Hereditary Cancer Testing Market was valued at 24.54 USD Million in 2024.
- The Malaysia Hereditary Cancer Testing Market is likely to grow at a CAGR of 19.71% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Direct Tender in Distribution Channel Segment accounted for the largest share of the market with a revenue of 17.12 USD Million
- The fastest growing segment Hospitals in End Users Segment grew Fastest with a CAGR of 20.50% during the forecast period from 2024 to 2032.
Malaysia Hereditary Cancer Testing Market Scope
Malaysia Hereditary Cancer Testing Market Segmentation & Scope
Disease
- Multiple Endocrine Neoplasias (MEN) Syndrome
- Von Hippel-Lindau Disease
- Li-Fraumeni Syndrome
- Familial Adenomatous Polyposis (FAP)
- Hereditary Leukemia and Hematologic Malignancies Syndrome
- Lynch Syndrome
- Cowden Syndrome
- Hereditary Breast & Ovarian Cancer Syndrome
Technology
- Microarray
- Sequencing
- Polymerase Chain Reaction (PCR)
Diagnosis
- Lab Tests
- Imagining
- Biopsy
Distribution Channel
- Retail Sales
- Direct Tender
End Users
- Others
- Laboratories
- Radiology Centres
- Diagnostics Centers
- Clinics
- Hospitals
Test
- Single Site Genetic Test
- Multi Panel Test
Malaysia Hereditary Cancer Testing Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 24.54 USD Million |
| Market Value in 2032 | 62.54 USD Million |
| CAGR (2025-2032) | 19.71% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Disease,Technology,Diagnosis,Distribution Channel,End Users,Test |
Regional Insights:
-
Leading Market (2024-2032): Malaysia, leading in terms of revenue 24.54 USD Million in 2024
- Key Country: Malaysia, leading in terms of revenue with value of 24.54 USD Million in 2024.
Segments and Scope
-
Malaysia Hereditary Cancer Testing Market to 2032, By Disease
- Hereditary Breast & Ovarian Cancer Syndrome is the largest segment in Malaysia Hereditary Cancer Testing Market to 2032 with a revenue of 14.58 USD Million in the year 2024.
- Hereditary Breast & Ovarian Cancer Syndrome is the Fastest growing segment in Malaysia Hereditary Cancer Testing Market to 2032 with a Growth rate of 20.27 % in forecast period 2025-2032.
-
Malaysia Hereditary Cancer Testing Market to 2032, By Technology
- Polymerase Chain Reaction (PCR) is the largest segment in Malaysia Hereditary Cancer Testing Market to 2032 with a revenue of 16.09 USD Million in the year 2024.
- Polymerase Chain Reaction (PCR) is the Fastest growing segment in Malaysia Hereditary Cancer Testing Market to 2032 with a Growth rate of 20.17 % in forecast period 2025-2032.
-
Malaysia Hereditary Cancer Testing Market to 2032, By Diagnosis
- Biopsy is the largest segment in Malaysia Hereditary Cancer Testing Market to 2032 with a revenue of 11.11 USD Million in the year 2024.
- Biopsy is the Fastest growing segment in Malaysia Hereditary Cancer Testing Market to 2032 with a Growth rate of 20.04 % in forecast period 2025-2032.
-
Malaysia Hereditary Cancer Testing Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Malaysia Hereditary Cancer Testing Market to 2032 with a revenue of 17.12 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in Malaysia Hereditary Cancer Testing Market to 2032 with a Growth rate of 19.87 % in forecast period 2025-2032.
-
Malaysia Hereditary Cancer Testing Market to 2032, By End Users
- Hospitals is the largest segment in Malaysia Hereditary Cancer Testing Market to 2032 with a revenue of 9.86 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in Malaysia Hereditary Cancer Testing Market to 2032 with a Growth rate of 20.50 % in forecast period 2025-2032.
-
Malaysia Hereditary Cancer Testing Market to 2032, By Test
- Multi Panel Test is the largest segment in Malaysia Hereditary Cancer Testing Market to 2032 with a revenue of 16.30 USD Million in the year 2024.
- Multi Panel Test is the Fastest growing segment in Malaysia Hereditary Cancer Testing Market to 2032 with a Growth rate of 20.09 % in forecast period 2025-2032.
Malaysia Hereditary Cancer Testing Market Company Share Analysis
| Company Name |
|
||
| PerkinElmer Inc. | |||
| illumina, inc. | |||
| Abbott | |||
| Eurofins Scientific | |||
| LifeLabs Genetics | |||
Malaysia Hereditary Cancer Testing Market Geographical Sales Distribution, 2018-2032 USD Million
Malaysia Hereditary Cancer Testing Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Malaysia Hereditary Cancer Testing Market is segmented based on Segmentation Disease,Technology,Diagnosis,Distribution Channel,End Users,Test.
Malaysia Hereditary Cancer Testing Market was valued at USD 24.54(Revenue in USD Million) in 2020.
Malaysia Hereditary Cancer Testing Market is projected to grow at a CAGR of 19.71% during the forecast period of 2024 to 2032.
The Direct Tender segment is expected to dominate the Malaysia Hereditary Cancer Testing Market, holding a largest market share of 17.12 USD Million in 2024
Malaysia Hereditary Cancer Testing Market Scope
Malaysia Hereditary Cancer Testing Market Segmentation & Scope
Disease
- Multiple Endocrine Neoplasias (MEN) Syndrome
- Von Hippel-Lindau Disease
- Li-Fraumeni Syndrome
- Familial Adenomatous Polyposis (FAP)
- Hereditary Leukemia and Hematologic Malignancies Syndrome
- Lynch Syndrome
- Cowden Syndrome
- Hereditary Breast & Ovarian Cancer Syndrome
Technology
- Microarray
- Sequencing
- Polymerase Chain Reaction (PCR)
Diagnosis
- Lab Tests
- Imagining
- Biopsy
Distribution Channel
- Retail Sales
- Direct Tender
End Users
- Others
- Laboratories
- Radiology Centres
- Diagnostics Centers
- Clinics
- Hospitals
Test
- Single Site Genetic Test
- Multi Panel Test
Frequently Asked Questions
The Malaysia Hereditary Cancer Testing Market is segmented based on Segmentation Disease,Technology,Diagnosis,Distribution Channel,End Users,Test.
Malaysia Hereditary Cancer Testing Market was valued at USD 24.54(Revenue in USD Million) in 2020.
Malaysia Hereditary Cancer Testing Market is projected to grow at a CAGR of 19.71% during the forecast period of 2024 to 2032.
The estimated market value of the Malaysia Hereditary Cancer Testing Market for final year is USD 62.54 (USD Million).
Malaysia Hereditary Cancer Testing Market Company Profiling
Frequently Asked Questions
The Malaysia Hereditary Cancer Testing Market is segmented based on Segmentation Disease,Technology,Diagnosis,Distribution Channel,End Users,Test.
Malaysia Hereditary Cancer Testing Market was valued at USD 24.54(Revenue in USD Million) in 2020.
Malaysia Hereditary Cancer Testing Market is projected to grow at a CAGR of 19.71% during the forecast period of 2024 to 2032.
The estimated market value of the Malaysia Hereditary Cancer Testing Market for final year is USD 62.54 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.